Targeting Inflammation to Lower Cardiovascular
Event Rates: Where do we stand in 2021?
Dr. Paul Ridker (USA)

Lipids – LDL-C Lowering for Secondary Prevention:
New Goals and New Tools
Dr. Laxmi Mehta (USA)